info@bronchiectasis-rti.org
Subscribe to our newsletter
Linkedin-in X-twitter
European Bronchiectasis Workshop
Respiratory Tract Infections
Register now

EBROW RTI 2027 CALLS

You are invited to submit an abstract of original research relevant to the conference topics for consideration as:

Rising Star*

Oral Presentation**

Poster Presentation***

TOPICS

The main topic areas have been determined and reflect key questions to be discussed:

EBROW

AI Tools
Bronchiectasis pipeline
CFTR Dysfunctions
Clinical Trials
Clinical Management of bronchiectasis
Exacerbations
Remote monitoring

EBROW + RTI

Bronchiectasis
Fungal disease
Impossible pathogens
NTM - Nontuberculous mycobacteria

RTI

Covid
Emerging antiviral approach
Pneumonia
Rapid Diagnostics
Tuberculosis
RSV

SUBMISSION DEADLINE: Monday 16 November 2026

GO TO THE SUBMISSION PAGE

General rules

CLICK HERE TO READ THE GENERAL RULES FOR THE SUBMISSION

RISING STAR*

EBROW RTI 2027 is keen to support the development of the next generation of researchers and clinicians. If you are a junior professional and would like to share your work, then this opportunity is for you!

To be eligible you have to meet at least one of the following criteria:

Age under 40 or fewer years since obtaining your PhDStill enrolled in a PhD programme

PURPOSE

You are invited to submit an original research abstract for consideration as an oral presentation within the conference’s main scientific programme.

THE CONCEPT

Two junior professionals, selected by a strict judging process, will have the opportunity to:

- Present a lecture in the main session of the program alongside international faculty members
- Be hosted by the conference, with your registration fee waived and your travel and accommodation costs covered

Compulsory Criteria

  • Abstracts should be related to the topics of the Conference
  • The candidate should be the first author of the abstract
  • The abstract should be original
  • The abstract should be presented in English
  • The candidate must not have previously served as faculty at an International Conference

Abstracts will be assessed by the conference Organizing and Scientific Committee, based primarily on their relevance and scientific merit.

Final selection will be at the Committee’s discretion. In the event of a tie, the following priority criteria will apply.

Priority Criteria

Age: Younger or less experienced professionals will have priority over the more senior / experienced professionals

Priority will be given to researchers / clinicians working in low-income countrieswith limited access to funds.

Acceptance

Notifications to submitters will be sent by the second week of December 2026.
Kindly note that if your Rising Star application is not accepted, it may still be selected for an oral or poster presentation.

ORAL PRESENTATION**

PURPOSE

You are invited to submit an abstract about research or a case report related to the topics of the scientific programme, for consideration as Oral Presentation.

THE CONCEPT

The Scientific Committee will select several Oral Presentations to be presented in the Plenary Room. Accepted Oral presenters will have the opportunity to:

  • Present their work in the main auditorium with Q&A from leading experts within the conference programme
  • Receive the personal feedback of the Presidents and Chairmen of the congress
  • Winners will have their profile and work included on the congress website and will gain a free registration.

Compulsory Criteria

The main selecting criteria will be the relevancy and scientific value of the abstract presented, evaluated by the Organizing and Scientific Committee of the conference. The choice will be made at the Committee discretion. In the case of equality, the following priority criteria will be applied.

Acceptance

Notifications to submitters will be sent by second week of December 2026.
Kindly note that if your Oral Presentation application is not accepted, it may still be selected for a Poster Presentation.

POSTER PRESENTATION ***

PURPOSE

You are invited to submit an abstract about research or a case report related to the topics of the scientific programme, for consideration as Poster Presentation.

THE CONCEPT

Accepted Poster presenters will have the opportunity to:

  • Display their poster in front of the audience of 350 specialists.
  • Discuss their work with the members of the scientific committee and the audience in the thematic poster sessions that will take place as follows:
    • EBROW Thematic poster sessions: 9 February from 13.00 to 14.00
    • RTI Thematic poster sessions: 11 February from 13.00 to 14.00
  • Compete for the Best poster prizes. Winners will have their profile and work included on the congress website and will gain a free registration of the next edition.

Compulsory Criteria

The main selecting criteria will be the relevancy and scientific value of the abstract presented, evaluated by the Organizing and Scientific Committee of the conference. The choice will be made at the Committee discretion. In the case of equality, the following priority criteria will be applied.

Acceptance

Notifications to submitters will be sent by second week of December 2026.

SUBMISSION DEADLINE: Monday 16 November 2026

GO TO THE SUBMISSION PAGE

General rules

CLICK HERE TO READ THE GENERAL RULES FOR THE SUBMISSION
Scientific Committee member 4
Member · EBROW Scientific Committee

Michal Shteinberg

Carmel Medical Center and the Technion, Haifa

Michal Shteinberg is heading the bronchiectasis and adult CF service in the Pulmonology institute and CF center, Carmel medical center, Haifa, Israel. She is a Clinical Assistant Professor in the Faculty of medicine at the Technion, Israel Institute of Technology. Her main research interests are bronchiectasis and its overlap with other airway diseases, and adult CF.

Scientific Committee member 5
Member · EBROW Scientific Committee

Oriol Sibila

Hospital Clínic de Barcelona, Spain

Head of the Pulmonology Service at Hospital Clínic de Barcelona and accredited researcher in the IDIBAPS group Inflammation and Repair in Respiratory Diseases. His work focuses on airway infection, inflammation and bronchiectasis, including frequent-exacerbator phenotypes in the EMBARC registry.

He coordinates educational programmes on bronchiectasis at Hospital Clínic and publishes widely on mucins, inhaled therapies and treatable traits in chronic airway disease.

Scientific Committee member 2
Member · EBROW Scientific Committee

Natalie Lorent

University Hospital Leuven, Belgium

Natalie Lorent works as a consultant in Respiratory Medicine/Clinical Infectiology at the University Hospital Leuven where since 2015 she coordinates the care for adults with respiratory infections, bronchiectasis (CF and non-CF) and primary ciliary dyskinesia. She is involved in clinical and translational research in bronchiectasis and mycobacterial infections.

She is founder and president of the national NTM Consilium, a clinical advisory board and basis of a national registry; she chairs the European NTM research network (NTMnet) and the Belgian MDRTB expert group. She has been involved in EMBARC since the start. Natalie is also assistant professor at KU Leuven.

Scientific Committee member 3
Member · EBROW Scientific Committee

Felix C. Ringshausen

Hannover Medical School (MHH) and German Center for Lung Research

Felix C. Ringshausen is a board-certified physician for respiratory medicine and infectious diseases and head of the Adult Bronchiectasis and Cystic Fibrosis Service at the Hannover Medical School, Germany. In addition, he is principal investigator of the German Center for Lung Research (DZL).

His research interests are focused on European multidisciplinary networks and multicenter initiatives in order to promote clinically orientated research and improve patient care in the field of rare, neglected and under-researched aspects of respiratory infections like bronchiectasis, nontuberculous mycobacteria, respiratory viruses and adult cystic fibrosis.

Scientific Committee member 1
Member · EBROW Scientific Committee

Stefano Aliberti

Humanitas University, Italy

Professor of Respiratory Medicine, Humanitas University, Milan, Italy. Consultant, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan.

Co-chair of the European Bronchiectasis Network (EMBARC). Chair of IRIDE, the Italian Registry of adult bronchiectasis. Chair of the Italian Registry on Non-Tuberculous Mycobacteria (IRENE).

Michael Loebinger
Co-chair · EBROW Organising Committee

Michael Loebinger

Royal Brompton Hospital · Imperial College London

Professor Michael Loebinger is Professor of Practice at Imperial College London and Director of the Lung Division and Deputy Medical Director at Royal Brompton Hospital. He co-chaired the British Thoracic Society bronchiectasis guidelines and co-wrote the BTS Non-Tuberculous Mycobacteria and European Respiratory Society bronchiectasis guidelines.

He is a founding member of the UK and European clinical and research bronchiectasis and NTM networks and has authored over 200 publications. He has helped design and lead multiple global clinical trials in bronchiectasis and NTM and was chief investigator for the first mRNA trials in primary ciliary dyskinesia.

Charles Haworth
Co-chair · EBROW Organising Committee

Charles Haworth

Royal Papworth Hospital, Cambridge, United Kingdom

Charles Haworth is a Respiratory Consultant working within the Cambridge Centre for Lung Infection at Royal Papworth Hospital where he specialises in treating adults with bronchiectasis, non-tuberculous mycobacterial (NTM) infections and cystic fibrosis.

He co-authored the British Thoracic Society Bronchiectasis clinical guidelines published in 2017 and the European Respiratory Society Bronchiectasis clinical guidelines published in 2019.

He was also senior author of the International Cystic Fibrosis NTM guidelines published in 2015 and first author of the British Thoracic Society NTM guidelines published in 2017.

From 2018 to 2021, he was a founding and executive committee member of the UK Cystic Fibrosis Medical Association.

In June 2024 he was invited to join the Board of the European Cystic Fibrosis Society.

James D. Chalmers
Co-chair · EBROW Organising Committee

James D. Chalmers

University of Oxford, United Kingdom

Rhodes Chair of Experimental Therapeutics and Clinical Pharmacology, University of Oxford.

Chief Editor of the European Respiratory Journal.

Chair of the European Bronchiectasis Network (EMBARC).

Chair of the Standards of Care Committee of the British Thoracic Society.